Literature DB >> 27581073

Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis.

Benjamin Knier1,2, Paul Schmidt1,3, Lilian Aly1,2, Dorothea Buck1, Achim Berthele1, Mark Mühlau1,4, Claus Zimmer5, Bernhard Hemmer1,4, Thomas Korn1,2,4.   

Abstract

Entities:  

Keywords:  clinical trials; imaging; multiple sclerosis biomarkers; neuroimmunology; neuroophthalmology

Mesh：

Year:  2016        PMID： 27581073     DOI： 10.1093/brain/aww219

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  38 in total

1.  Spinal cord and infratentorial lesions in radiologically isolated syndrome are associated with decreased retinal ganglion cell/inner plexiform layer thickness.

Authors:  Angeliki Filippatou; Thomas Shoemaker; Megan Esch; Madiha Qutab; Natalia Gonzalez-Caldito; Jerry L Prince; Ellen M Mowry; Peter A Calabresi; Shiv Saidha; Elias S Sotirchos
Journal:  Mult Scler       Date:  2018-12-03       Impact factor: 6.312

2.  Patients with multiple sclerosis demonstrate reduced subbasal corneal nerve fibre density.

Authors:  Janine Mikolajczak; Hanna Zimmermann; Ahmad Kheirkhah; Ella Maria Kadas; Timm Oberwahrenbrock; Rodrigo Muller; Aiai Ren; Joseph Kuchling; Holger Dietze; Harald Prüss; Friedemann Paul; Pedram Hamrah; Alexander U Brandt
Journal:  Mult Scler       Date:  2016-11-03       Impact factor: 6.312

3.  Deep learning based topology guaranteed surface and MME segmentation of multiple sclerosis subjects from retinal OCT.

Authors:  Yufan He; Aaron Carass; Yihao Liu; Bruno M Jedynak; Sharon D Solomon; Shiv Saidha; Peter A Calabresi; Jerry L Prince
Journal:  Biomed Opt Express       Date:  2019-09-12       Impact factor: 3.732

4.  Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.

Authors:  Natalia Gonzalez Caldito; Shiv Saidha; Elias S Sotirchos; Blake E Dewey; Norah J Cowley; Jeffrey Glaister; Kathryn C Fitzgerald; Omar Al-Louzi; James Nguyen; Alissa Rothman; Esther Ogbuokiri; Nicholas Fioravante; Sydney Feldman; Ohemaa Kwakyi; Hunter Risher; Dorlan Kimbrough; Teresa C Frohman; Elliot Frohman; Laura Balcer; Ciprian Crainiceanu; Peter C M Van Zijl; Ellen M Mowry; Daniel S Reich; Jiwon Oh; Dzung L Pham; Jerry Prince; Peter A Calabresi
Journal:  Brain       Date:  2018-11-01       Impact factor: 13.501

5.  Association of Retinal Architecture, Intrathecal Immunity, and Clinical Course in Multiple Sclerosis.

Authors:  Benjamin Knier; Gildas Leppenetier; Carmen Wetzlmair; Lilian Aly; Muna-Miriam Hoshi; Verena Pernpeintner; Viola Biberacher; Achim Berthele; Mark Mühlau; Claus Zimmer; Bernhard Hemmer; Thomas Korn
Journal:  JAMA Neurol       Date:  2017-07-01       Impact factor: 18.302

Review 6.  Can Optical Coherence Tomography Be Used to Guide Treatment Decisions in Adult or Pediatric Multiple Sclerosis?

Authors:  Jeffrey Lambe; Olwen C Murphy; Shiv Saidha
Journal:  Curr Treat Options Neurol       Date:  2018-03-21       Impact factor: 3.598

Review 7.  Monitoring the Course of MS With Optical Coherence Tomography.

Authors:  Alexander U Brandt; Elena H Martinez-Lapiscina; Rachel Nolan; Shiv Saidha
Journal:  Curr Treat Options Neurol       Date:  2017-04       Impact factor: 3.598

8.  Use of Corneal Confocal Microscopy to Detect Corneal Nerve Loss and Increased Dendritic Cells in Patients With Multiple Sclerosis.

Authors:  Gulfidan Bitirgen; Zehra Akpinar; Rayaz A Malik; Ahmet Ozkagnici
Journal:  JAMA Ophthalmol       Date:  2017-07-01       Impact factor: 7.389

9.  Discriminative power of intra-retinal layers in early multiple sclerosis using 3D OCT imaging.

Authors:  Caspar B Seitz; Amgad Droby; Lena Zaubitzer; Julia Krämer; Mathieu Paradis; Luisa Klotz; Heinz Wiendl; Sergiu Groppa; Sven G Meuth; Frauke Zipp; Vinzenz Fleischer
Journal:  J Neurol       Date:  2018-08-02       Impact factor: 4.849

Review 10.  [Optical coherence tomography in neuromyelitis optica spectrum disorders].

Authors:  F C Oertel; H Zimmermann; A U Brandt; F Paul
Journal:  Nervenarzt       Date:  2017-12       Impact factor: 1.214
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.